If you are fully vaccinated, you can start doing many things that you had stopped doing because of the pandemic.
More
The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen(Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
More
Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases
More
The ACT Accelerator partnership welcomes over US$ 4.3 billion of new investments from the USA, Germany, the European Commission, Japan, and Canada to fund the development and equitable rollout of the tests, treatments and vaccines needed to end the acute phase of the COVID-19 pandemic.
More
MEPs will debate the Covid-19 crisis and recovery with members of national pariaments, discuss vaccine production and vote on a strategy for tourism.
More
The World Health Organization (WHO) today listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX.
More
The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt if they are to remain effective against them.
More
Even as the pace of vaccination against covid-19 has steadily accelerated — hitting an average of 1.3 million doses a day in the last days of January — the frustration felt by many of those unable to secure an appointment hasn’t waned.
More
April 30 will mark the end of the first 100 days of President Joe Biden’s tenure. That’s a benchmark presidents often set for making good on high-priority campaign promises.
More